Trial Profile
A pilot study of Bertilimumab in patients with Crohn's disease
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Bertilimumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 19 Aug 2015 New trial record